Although it remains unclear precisely how administering a HFD leads to hepatic fibrosis and HCC development, the accumulating evidence may indicate potential pathophysiological mechanisms, including insulin resistance, inflammatory cascades, and oxidative stress [38]. The gene discussed is INS; the disease is hepatocellular carcinoma.